Prevention of postoperative nausea and vomiting and reduction of analgesic requirement by use of dexamethasone, dexmedetomidine and combination of dexamethasone-dexmedetomidine.
Phase 4
Completed
- Conditions
- Health Condition 1: N859- Noninflammatory disorder of uterus, unspecified
- Registration Number
- CTRI/2019/08/020888
- Lead Sponsor
- Apollo Hospitals Bilaspur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA grade I and II
2. Scheduled for laparoscopic gynaecological surgery under general anesthesia
Exclusion Criteria
1.Known allergy to study drugs
2.Use of antiemetic drugs within 24 hours of surgery
3.Morbid obesity( body mass index >40)
4.Chronic use of opioids
5.Patients with hepatic, renal or cardiovascular dysfunction
6.Psychiatric patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method